3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
4
Completed
3
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
10
Neoplasms
5
Colorectal Neoplasms
4
Neoplasm Metastasis
3
Prostatic Neoplasms
2
Lung Neoplasms
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Skin Carcinoma
1
Postoperative Complications
1
Polycystic Ovary Syndrome
1
Peripheral Arterial Disease
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Pain
1
Opioid-Related Disorders
1
Nausea
1
Multiple Myeloma
1
Mouth Neoplasms
1
Motor Activity
1
Melanoma
1
Medication Adherence
1
Malignant Solid Neoplasm
1
Lymphoma, Follicular
1
Localised Prostate Cancer
1
Laryngeal Neoplasms
1
Ischemia
1
Hypertension
1
Hemianopsia
1
Interventions
Carboplatin
12
pembrolizumab
8
Paclitaxel
8
Cyclophosphamide
8
toripalimab
4
sacituzumab govitecan
4
olaparib
4
Epirubicin
4
Drug Therapy
4
Doxorubicin
4
eribulin
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
Radiotherapy
2
Injections
2
Gemcitabine
2
taxane
1
poly ICLC
1
pirfenidone
1
palbociclib
1
ivarmacitinib
1
inavolisib
1
fludarabine
1
daratumumab
1
camrelizumab
1
axatilimab
1
anlotinib
1
aldesleukin
1
Vinorelbine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Triple Negative Breast Neoplasms
×
Standard of Care
×
Clear all
NCT07486687
2026-03-20
PLANET
The Netherlands Cancer Institute
Phase 3
Not yet recruiting
1,000 enrolled